Your browser doesn't support javascript.
loading
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.
Huffman, Austin P; Richman, Lee P; Crisalli, Lisa; Ganetsky, Alex; Porter, David L; Vonderheide, Robert H; Reshef, Ran.
Affiliation
  • Huffman AP; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Division of Hematology/Oncology and the Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Richman LP; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania.
  • Crisalli L; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ganetsky A; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Porter DL; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Vonderheide RH; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania.
  • Reshef R; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Division of Hematology/Oncology and the Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York. Electronic address:
Biol Blood Marrow Transplant ; 24(3): 594-599, 2018 03.
Article in En | MEDLINE | ID: mdl-29061535
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 4_TD Database: MEDLINE Main subject: Receptors, CCR5 / CCR5 Receptor Antagonists / Maraviroc / Graft vs Host Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 4_TD Database: MEDLINE Main subject: Receptors, CCR5 / CCR5 Receptor Antagonists / Maraviroc / Graft vs Host Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Year: 2018 Document type: Article